NRAS c.181_182delinsGT ;(p.Q61V)

Variant ID: 1-115256529-TG-AC

NM_002524.4(NRAS):c.181_182delinsGT;(p.Q61V)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


RAS-targeted cancer therapy: Advances in drugging specific mutations.

Medcomm
Liu, Cen C; Ye, Danyang D; Yang, Hongliu H; Chen, Xu X; Su, Zhijun Z; Li, Xia X; Ding, Mei M; Liu, Yonggang Y
Publication Date: 2023-06

Variant appearance in text: NRAS: Q61V
PubMed Link: 37250144
Variant Present in the following documents:
  • Main text
View BVdb publication page



MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.

Frontiers In Oncology
Eleveld, Thomas F TF; Vernooij, Lindy L; Schild, Linda L; Koopmans, Bianca B; Alles, Lindy K LK; Ebus, Marli E ME; Dandis, Rana R; van Tinteren, Harm H; Caron, Huib N HN; Koster, Jan J; van Noesel, Max M MM; Tytgat, Godelieve A M GAM; Eising, Selma S; Versteeg, Rogier R; Dolman, M Emmy M MEM; Molenaar, Jan J JJ
Publication Date: 2023

Variant appearance in text: NRAS: Q61V
PubMed Link: 36895472
Variant Present in the following documents:
  • Main text
  • fonc-13-1130034.pdf
View BVdb publication page



Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions.

Cancers
Zaremba, Anne A; Jansen, Philipp P; Murali, Rajmohan R; Mayakonda, Anand A; Riedel, Anna A; Krahl, Dieter D; Burkhardt, Hans H; John, Stefan S; Géraud, Cyrill C; Philip, Manuel M; Kretz, Julia J; Möller, Inga I; Stadtler, Nadine N; Sucker, Antje A; Paschen, Annette A; Ugurel, Selma S; Zimmer, Lisa L; Livingstone, Elisabeth E; Horn, Susanne S; Plass, Christoph C; Schadendorf, Dirk D; Hadaschik, Eva E; Lutsik, Pavlo P; Griewank, Klaus K
Publication Date: 2022-08-23

Variant appearance in text: NRAS: Q61V
PubMed Link: 36077603
Variant Present in the following documents:
  • Main text
  • cancers-14-04066.pdf
View BVdb publication page



Ca2+ as a therapeutic target in cancer.

Advances In Cancer Research
Gross, Scott S; Mallu, Pranava P; Joshi, Hinal H; Schultz, Bryant B; Go, Christina C; Soboloff, Jonathan J
Publication Date: 2020

Variant appearance in text: NRAS: Q61V
PubMed Link: 32723565
Variant Present in the following documents:
  • Main text
View BVdb publication page



A Comparative Analysis of Individual RAS Mutations in Cancer Biology.

Frontiers In Oncology
Muñoz-Maldonado, Carmen C; Zimmer, Yitzhak Y; Medová, Michaela M
Publication Date: 2019

Variant appearance in text: NRAS: Q61V
PubMed Link: 31681616
Variant Present in the following documents:
  • fonc-09-01088.pdf
View BVdb publication page



Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.

Bmc Cancer
Heppt, Markus V MV; Siepmann, Timo T; Engel, Jutta J; Schubert-Fritschle, Gabriele G; Eckel, Renate R; Mirlach, Laura L; Kirchner, Thomas T; Jung, Andreas A; Gesierich, Anja A; Ruzicka, Thomas T; Flaig, Michael J MJ; Berking, Carola C
Publication Date: 2017-08-10

Variant appearance in text: NRAS: Q61V
PubMed Link: 28797232
Variant Present in the following documents:
  • Main text
  • 12885_2017_Article_3529.pdf
View BVdb publication page



A comprehensive survey of Ras mutations in cancer.

Cancer Research
Prior, Ian A IA; Lewis, Paul D PD; Mattos, Carla C
Publication Date: 2012-05-15

Variant appearance in text: NRAS: Q61V
PubMed Link: 22589270
Variant Present in the following documents:
  • Main text
View BVdb publication page